Farther Finance Advisors’s Biomerica BMRA Stock Holding History

Farther Finance Advisors’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-169	Closed	-$478	–	5473
2025 Q3	$478	Buy	+169	New	+$535	﹤0.01%	4554

Other funds holding BMRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Farther Finance Advisors's BMRA Position: Q4 2025 in Review

Farther Finance Advisors sold out of Biomerica (BMRA) in Q4 2025, closing a stake of 169 shares — an estimated $478 sold.

Farther Finance Advisors first reported a position in BMRA in Q3 2025 and held it in 1 quarter. The position peaked at $478 in Q3 2025. 13 funds tracked by Wall St. Rank hold BMRA as of Q4 2025.

Farther Finance Advisors reported no remaining Biomerica position as of Q4 2025 after selling out during the quarter.
Farther Finance Advisors sold 169 Biomerica shares in Q4 2025, an estimated $478.
Farther Finance Advisors first reported a position in Biomerica in Q3 2025 and held it in 1 quarter.
Farther Finance Advisors's Biomerica position peaked at $478 in Q3 2025.
13 funds tracked by Wall St. Rank held Biomerica as of Q4 2025.

Based on Farther Finance Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.